Monashee Investment Management’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-105,493
Closed -$236K 143
2024
Q1
$236K Sell
105,493
-16,348
-13% -$55.1K 0.03% 104
2023
Q4
$454K Sell
121,841
-20,000
-14% -$105K 0.08% 40
2023
Q3
$896K Buy
+141,841
New +$1.13M 0.37% 59
2020
Q4
Sell
-33,467
Closed -$5.48M 331
2020
Q3
$5.48M Buy
33,467
+27,467
+458% +$4.88M 1.18% 10
2020
Q2
$1.24M Sell
6,000
-6,293
-51% -$1.46M 0.19% 124
2020
Q1
$2.45M Sell
12,293
-3,707
-23% -$812K 1.31% 7
2019
Q4
$3.36M Buy
+16,000
New +$2.3M 3.13% 7
2018
Q3
Hold
0
107

Other funds holding MTEM

Monashee Investment Management's MTEM Position: Q2 2024 in Review

Monashee Investment Management sold out of Molecular Templates, Inc. (MTEM) in Q2 2024, closing a stake of 105,493 shares — an estimated $236K sold.

Monashee Investment Management first reported a position in MTEM in Q4 2019 and held it in 7 quarters. The position peaked at $5.48M in Q3 2020. 28 funds tracked by Wall St. Rank hold MTEM as of Q2 2024.

  • Monashee Investment Management reported no remaining Molecular Templates, Inc. position as of Q2 2024 after selling out during the quarter.
  • Monashee Investment Management sold 105,493 Molecular Templates, Inc. shares in Q2 2024, an estimated $236K.
  • Monashee Investment Management first reported a position in Molecular Templates, Inc. in Q4 2019 and held it in 7 quarters.
  • Monashee Investment Management's Molecular Templates, Inc. position peaked at $5.48M in Q3 2020.
  • 28 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2024.

Based on Monashee Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.